http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104034902-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2014-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104034902-B |
titleOfInvention | Utilize the kit of 4 albumen associated prediction esophageal cancer patients prognosis |
abstract | Technical matters to be solved by this invention is to provide a kind of reagent detecting destination protein expression in paraffin-embedded tissue.The technical scheme that the present invention solves this technical problem there is provided a kind of detection kit evaluating esophageal cancer patients prognosis information.This kit comprises antibody-δ-catenin, Dynamin-2, Erbin and LAP-1 antibody of 4 kinds of destination proteins, also comprises lowlenthal serum, 0.01M citrate repairs liquid, 3%Hn 2 on 2 , Polymer reinforcing agent, Polymer polymkeric substance, DAB chromogenic reagent, PBS solution.Use the prognosis of this kit evaluation esophageal cancer patients by stages more simple than international TNM, and susceptibility and specificity are all higher than TNM by stages, and are more suitable for the cancer of the esophagus prognosis evaluation of compatriots. |
priorityDate | 2014-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.